UK Penny Stocks To Watch In August 2026

The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices slipping due to weak trade data from China, highlighting global economic uncertainties. Amidst these conditions, investors might find opportunities in penny stocks—smaller or less-established companies that can still present significant value. Although the term "penny stocks" may seem outdated, these investments can offer potential growth for those who focus on firms with strong financials and a clear path forward.

Here we highlight a subset of our preferred stocks from the screener.

Poolbeg Pharma (AIM:POLB)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company focused on developing immunotherapy for cancer in the United Kingdom, with a market cap of £63.37 million.

Operations: Poolbeg Pharma PLC has not reported any specific revenue segments.

Market Cap: £63.37M

Poolbeg Pharma, with a market cap of £63.37 million, is currently pre-revenue and unprofitable. Despite this, the company has made significant strides in its intellectual property strategy for POLB 001, a promising cancer immunotherapy-induced Cytokine Release Syndrome (CRS) treatment. Recent achievements include patent grants in Europe and Canada, bolstering its competitive position globally. The ongoing TOPICAL clinical trial is generating interest within the haematology community and could be pivotal for future partnerships. A recent £3.5 million equity offering strengthens Poolbeg's financial runway as it advances POLB 001 through clinical stages and potential commercialisation pathways.

• Get an in-depth perspective on Poolbeg Pharma's performance by reading our balance sheet health report here.
• Evaluate Poolbeg Pharma's historical performance by accessing our past performance report.

Funding Circle Holdings (LSE:FCH)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Funding Circle Holdings plc operates online lending platforms in the United Kingdom and internationally, with a market capitalization of £676.90 million.

Operations: The company generates revenue through its Flexipay segment, contributing £36.9 million, and Term Loans segment, which accounts for £167.4 million.

Market Cap: £676.9M

Funding Circle Holdings, with a market cap of £676.90 million, has demonstrated robust financial growth, evidenced by an impressive earnings surge of 15,233.3% over the past year and a net profit margin increase to 22.5%. The company's debt management is prudent; its short-term assets exceed both short and long-term liabilities, and it holds more cash than total debt. However, operating cash flow remains negative. Recent developments include the launch of a new mobile app enhancing FlexiPay services for SMEs and board changes aimed at supporting future growth phases. The company reaffirmed its revenue guidance for fiscal year 2026 at £235 million.

• Jump into the full analysis health report here for a deeper understanding of Funding Circle Holdings.
• Gain insights into Funding Circle Holdings' outlook and expected performance with our report on the company's earnings estimates.

Genel Energy (LSE:GENL)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Genel Energy plc is an independent oil and gas exploration and production company with a market cap of £172.78 million.

Operations: The company generates $68.7 million from its production activities.

Market Cap: £172.78M

Genel Energy, with a market cap of £172.78 million, faces challenges as it remains unprofitable despite reducing losses by 44.9% annually over the past five years. It has a robust cash position exceeding its total debt and short-term assets covering liabilities, providing a cash runway for over three years even with shrinking free cash flow. Recent earnings show a significant decline in sales to US$13.4 million and a net loss of US$17.4 million for H1 2026 compared to the previous year’s profit. A proposed acquisition by DNO Iraq AS values Genel at £200 million but remains non-binding after board rejection.

• Unlock comprehensive insights into our analysis of Genel Energy stock in this financial health report.
• Examine Genel Energy's earnings growth report to understand how analysts expect it to perform.

Taking Advantage

• Get an in-depth perspective on all 276 UK Penny Stocks by using our screener here.
• Contemplating Other Strategies? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com